The expression of EFNA1 was high in bladder urothelial carcinoma (BLCA), EFNA2 was highest in stomach adenocarcinoma (STAD), and EFNA3 was highest in lung squamous cell carcinoma (LUSC). This evidence concerns the gene EFNA3 and squamous cell lung carcinoma.